Targeting of iNOS with antisense DNA plasmid reduces cytokine-induced inhibition of osteoblastic activity

被引:8
作者
Abe, T
Hikiji, H
Shin, WS
Koshikiya, N
Shima, S
Nakata, J
Susami, T
Takato, T
Toyo-oka, T
机构
[1] Univ Tokyo, Fac Med, Dept Oral & Maxillofacial Surg, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Fac Med, Dept Organ Pathophysiol, Bunkyo Ku, Tokyo 1138655, Japan
[3] Univ Tokyo, Fac Med, Dept Internal Med, Bunkyo Ku, Tokyo 1138655, Japan
[4] Univ Tokyo, Fac Med, Hlth Serv Ctr, Bunkyo Ku, Tokyo 1138655, Japan
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2003年 / 285卷 / 03期
关键词
inducible nitric oxide synthase; antisense; peroxynitrite; osteoblast;
D O I
10.1152/ajpendo.00267.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proinflammatry cytokines, tumor necrosis factor-alpha combined with interleukin-1beta, induce excessive production of nitric oxide (NO) and its cytotoxic metabolite peroxynitrite (ONOO-) via inducible nitric oxide synthase (iNOS) in murine osteoblasts. In this study, to properly estimate the effects of antisense DNA of iNOS on osteoblastic activity, we produced transformed cell lines with antisense plasmid that specifically targets the iNOS gene for potential long-lasting inhibition. Transformed antisense cell lines were identified by 1) the detection of antisense transcripts, 2) the attenuated expression of iNOS protein, 3) the reduction of NO synthase activity, and 4) the level of NO production. These cell lines targeting iNOS, which showed decreased production of both NO and ONOO-, prevented the inhibition of osteoblastic differentiation as was assayed by the mRNA expression of type I collagen, alkaline phosphatase, osteocalcin, and Core binding factor in the presence of proinflammatory cytokines. Present results indicate that the antisense DNA plasmid of iNOS is potent to reduce the cytokine-induced inhibition of osteoblastic activity.
引用
收藏
页码:E614 / E621
页数:8
相关论文
共 45 条
[1]   Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase [J].
Armour, KE ;
Armour, KJ ;
Gallagher, ME ;
Gödecke, A ;
Helfrich, MH ;
Reid, DM ;
Ralston, SH .
ENDOCRINOLOGY, 2001, 142 (02) :760-766
[2]   Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis [J].
Armour, KE ;
Van't Hof, RJ ;
Grabowski, PS ;
Reid, DM ;
Ralston, SH .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (12) :2137-2142
[3]  
Armour KJ, 2001, ARTHRITIS RHEUM, V44, P2790, DOI 10.1002/1529-0131(200112)44:12<2790::AID-ART466>3.0.CO
[4]  
2-X
[5]   STIMULATION OF BONE-RESORPTION AND INHIBITION OF BONE-FORMATION INVITRO BY HUMAN-TUMOR NECROSIS FACTORS [J].
BERTOLINI, DR ;
NEDWIN, GE ;
BRINGMAN, TS ;
SMITH, DD ;
MUNDY, GR .
NATURE, 1986, 319 (6053) :516-518
[6]  
BOLGLE RG, 1995, AM J PHYSIOL-CELL PH, V269, pC750
[7]   BIDIRECTIONAL REGULATION OF OSTEOCLAST FUNCTION BY NITRIC-OXIDE SYNTHASE ISOFORMS [J].
BRANDI, ML ;
HUKKANEN, M ;
UMEDA, T ;
MORADIBIDHENDI, N ;
BIANCHI, S ;
GROSS, SS ;
POLAK, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2954-2958
[8]   Inhibition of nitric oxide synthase by antisense techniques: Investigations of the roles of NO produced by murine macrophages [J].
Cartwright, JE ;
Johnstone, AP ;
Whitley, GS .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (01) :146-152
[9]   Endogenously produced nitric oxide inhibits endothelial cell growth as demonstrated using novel antisense cell lines [J].
Cartwright, JE ;
Johnstone, AP ;
Whitley, GS .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (01) :131-137
[10]  
Crow JP, 1996, METHOD ENZYMOL, V269, P185